Clinical trials recruiting for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| HBI0101 CART | 1 |
| Universal CD19 CAR-γδT Cell Injection | 1 |
Self-screener
Recruiting trials
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Related conditions
Trials recruiting for Neuromyelitis Optica Spectrum Disorder (NMOSD) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Neuromyelitis Optica Spectrum Disorder (NMOSD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.